美满霉素胶囊治疗非淋菌性尿道炎36例疗效观察

目的观察美满霉素(盐酸米诺环素微丸胶囊)治疗非淋菌性尿道(宫颈)炎(NGU)的临床疗效.方法选择门诊NGU66例,将患者随机分为治疗组及对照组,治疗组口服美满霉素胶囊0.1g,首次加倍,2次/d,连续15天;对照组口服罗红霉素胶囊0.15g,2次/d,连续15天.结果治疗组治愈率为83.3%,总有效率为94.4%.对照组治愈率为46.7%,总有效率为76.7%.两组疗效差异有显著性X2=13.32,P＜0.01.结论美满霉素胶囊治疗非淋菌性尿道炎(宫颈炎),疗效显著.     

美满霉素胶囊治疗非淋菌性尿道炎36例疗效观察

目的 观察美满霉素（盐酸米诺环素微丸胶囊）治疗非淋菌性尿道（宫颈）炎（NGU）的临床疗效。方法 选择门诊NGU66例，将患者随机分为治疗组及对照组，治疗组口服美满霉素胶囊0．1g，首次加倍，2次／d，连续15天；对照组口服罗红霉素胶囊0．15g，2次／d，连续15天。结果 治疗组治愈率为83．3％，总有效率为94．4％。对照组治愈率为46．7％，总有效率为76．7％。两组疗效差异有显著性X^2=13．32，P〈0．01。结论 美满霉素胶囊治疗非淋菌性尿道炎（宫颈炎），疗效显著。     

复方莪术油栓联合阿奇霉素治疗非淋菌性尿道(宫颈)炎68例疗效观察

目的观察复方莪术油栓局部用药联合阿奇霉素治疗由沙眼衣原体(CT)和解脲支原体(UU)感染引起的非淋菌性尿道(宫颈)炎的疗效。方法将门诊确诊为非淋菌性尿道(宫颈)炎68例患者,局部用复方莪术油栓联合口服阿奇霉素疗程7天,停药1周后,随诊观察疗效。结果沙眼衣原体有效率100%,解脲支原体有效率80%,混合感染有效率88%。结论复方莪术油栓联合阿奇霉素冶疗非淋菌性尿道(宫颈)炎效果好。     

阿奇霉素联合盐酸洛美沙星治疗非淋菌性尿道炎的临床研究

目的 为提高临床治愈率,了解阿奇霉素联合盐酸洛美沙星治疗非淋菌性尿道(宫颈)炎的临床应用价值.方法 选择2009年1月-2011年12月接受治疗的200例患者,将其随机分为观察组和对照组,每组各100例；对照分析两组临床疗效、病原学清除、总疗效及不良反应.结果 观察组治愈率85.0％、显效率7.0％,显著高于对照组的54.0％、14.0％；观察组病原体全清除率94.0％,显著高于对照组的72.0％,两组差异均有统计学意义(P＜0.05).结论 阿奇霉素联合盐酸洛美沙星治疗非淋菌性尿道(宫颈)炎,临床疗效好,病原体清除率高,值得临床推广使用.     

阿奇霉素与加替沙星治疗非淋菌性尿道(宫颈)炎的药物经济学分析

[目的]比较注射用阿奇霉素与加替沙星治疗非淋菌性尿道(宫颈)炎所产生的经济成本.[方法]选择60例非淋菌性尿道(宫颈)炎患者,随机分为2组,分别给予阿奇霉素(A组)、加替沙星(B组)治疗.运用药物经济学的最小成本分析方法进行评价.[结果]A组、B组所需药品成本分别是242.00元、630.00元.有效率分别是92.86%、93.75%(P＞0.05).[结论]阿奇霉素相对于加替沙星治疗非淋菌性尿道(宫颈)炎具有明显的药物经济学优势.     

复方莪术油栓联合阿奇霉素治疗非淋菌性尿道（宫颈）炎68例疗效观察

目的观察复方莪术油栓局部用药联合阿奇霉素治疗由沙眼衣原体（CT）和解脲支原体（UU）感染引起的非淋菌性尿道（宫颈）炎的疗效。方法将门诊确诊为非淋菌性尿道（宫颈）炎68例患者，局部用复方莪术油栓联合口服阿奇霉素疗程7天，停药1周后，随诊观察疗效。结果沙眼衣原体有效率100％，解脲支原体有效率80％，混合感染有效率88％。结论复方莪术油栓联合阿奇霉素冶疗非淋菌性尿道（宫颈）炎效果好。     

司帕沙星治疗非淋菌性尿道(宫颈)炎85例

目的探讨司帕沙星治疗非淋菌性尿道(宫颈)炎的疗效.方法对85例非淋菌性尿道(宫颈)炎予口服司帕沙星后的阴转情况进行疗效分析.结果85例痊愈56例,显效20例,总有效率89.41%,其中CT单独感染者总有效率90.7%,UU单独感染者总有效率88.89%.CT+UU混合感染者总有效率86.67%.结论治疗非淋菌性尿道(宫颈)炎,口服司帕沙星是一种前景良好,使用方便、安全的有效药物,值得临床推广应用.     

加替沙星与克拉霉素联合治疗男性非淋菌性尿道炎疗效观察

目的观察加替沙星与克拉霉素联合治疗非淋菌性尿道炎(NGU)的临床疗效。方法将门诊确诊为NGU的患者180例随机分为治疗组和对照组(各90例),治疗组应用加替沙星与克拉霉素口服治疗,对照组应用克拉霉素口服治疗,均14天为1疗程。结果治疗组总有效率为95.6%,对照组总有效率为81.1%。病原体转阴治疗组明显高于对照组。结论加替沙星与克拉霉素联合治疗男性NGU是一种较好的治疗方法。     

74例非淋菌性宫颈炎的临床治疗效果分析

目的探讨壳聚糖宫颈抗菌膜联合多西环素治疗非淋菌性宫颈炎的治疗效果。方法选取2015年1月-2016年8月吉林市北华大学附属医院收治的非淋菌性宫颈炎患者74例为研究对象,随机分为观察组和对照组各37例,对照组采取多西环素进行治疗,观察组采取壳聚糖宫颈抗菌膜联合多西环素进行治疗,比较两组患者的临床疗效和不良反应。结果治疗后,观察组总有效率为94.59%明显高于对照组的81.08%,差异有统计学意义(P0.05);治疗后,观察组不良反应发生率为8.11%明显低于对照组的18.92%,差异有统计学意义(P0.05)。结论非淋菌性宫颈炎采取壳聚糖宫颈抗菌膜联合多西环素共同治疗,不但治疗效果可靠,同时不良反应也较少,具有较高的临床应用价值。     

非淋菌性泌尿生殖道炎患者支原体感染情况及耐药性分析

目的 了解本地区非淋菌性泌尿生殖道炎支原体感染情况及耐药情况.方法 选择我院性病门诊3 104例患者进行解脲支原体、人型支原体检查,对492例支原体阳性患者进行解脲支原体、人型支原体的药物敏感性检测.结果 解脲支原体、人型支原体及解脲支原体加人型支原体的感染率分别为38.92%、0.35%、1.35%,女性感染率高于男性感染率;20～50岁是非淋菌性尿道(宫颈)炎患者高发年龄段;支原体对美满霉素、强力霉素和四环素最为敏感,而对红霉素和环丙沙星耐药性最强.结论 解脲支原体、人型支原体是泌尿生殖道的主要感染菌,其中解脲支原体感染率最高,而中青年是主要感染人群.对支原体感染患者,应进行药物敏感检测指导临床治疗.     

联合用药治疗顽固性非淋菌性泌尿生殖道炎的探讨

应用氧氟沙星、阿齐红霉素、可乐必妥联合用药对100例病程13年，曾多次单剂量用药治疗，尿道炎、宫颈炎症状长期反复存在的顽固性非淋菌性泌尿生殖道炎进行治疗，有效率为100%，治愈率为87％，提示三种药物协同作用可增强治疗效果，缩短治疗时间，减少耐药性，具有临床应用价值。     

中西医结合治疗非淋菌性尿道炎、宫颈炎的临床研究

目的:探索中西医结合治疗由支原体、衣原体引起的泌尿生殖道感染的临床效果。方法:将自愿参与治疗的120例患者随机分为中西医组、中医药组、西医药组,各40例,分别用药治疗10天为一个疗程,观察疗效。结果:有效率中西医组100%、中医药组97·5%、西医药组87·5%,中西医组、中医药组与西医药组相比差别有显著性意义(P<0·05);病原体清除率中西医组92·5%,中医药组75·0%,西医药组67·5%,中西医药组与西医药组相比差别有显著性意义(P<0·05)。结论:中医辨证与西医辨病相结合,合理使用抗生素,同时结合中药治疗非淋菌性尿道炎、宫颈炎,疗效显著。     

中西医结合治疗慢性盆腔炎56例临床观察

目的探讨中西医结合治疗慢性盆腔炎的临床效果。方法选取慢性盆腔炎患者100例,随机分为两组,对照组44例,观察组56例,两组患者在年龄、婚姻、性伙伴、病程、病史等方面无明显差异,有可比性。对照组患者采取单纯西医治疗．观察组在对照组基础上给予中西医结合治疗。于治疗后对两组患者进行查体,记录两组患者阳性体征,并对两组患者治疗效果进行评价。结果经过治疗,观察组患者的阳性体征发生率为17．86％,明显少于对照组50．00％的比例;观察组患者临床治愈率及有效率分别为60．71％和91．07％,明显高于对照组38．64％和79．55％的比例。上述比较两组差异明显,有统计学意义（P〈0．05）。结论中西医结合治疗慢性盆腔炎更有利于改善患者体质,取得良好的治疗效果。     

生殖器支原体在HIV高危人群中的流行进展

生殖器支原体(Mg)是性传播疾病的病原之一,可引起男性非淋球菌性尿道炎、女性宫颈炎、子宫内膜炎及盆腔炎.近年来发现泌尿生殖道Mg感染在HIV阳性及高危人群中的流行呈上升趋势,并且Mg感染可能促进HIV的感染与传播,提示应对HIV高危人群的Mg感染给予充分的重视.此文就Mg在HIV阳性及高危人群中的流行情况及治疗的研究进展进行了综述.     

综合疗法治疗慢性盆腔炎的临床观察

[目的]观察中西药及微波综合治疗慢性盆腔炎的疗效。[方法]慢性盆腔炎患者共284例,随机分为两组,治疗组和观察组各142例,治疗组采用经期抗生素静脉点滴,经间期康复消炎栓直肠给药,并配合微波综合治疗;对照组采用单纯经期抗生素静脉点滴治疗。比较两组患者治疗后的临床效果。[结果]治疗组的总有效率为95.77%,对照组总有效率为77.46%,明显高于对照组,两组比较差异有统计学意义（χ^2=20.537,P﹤0.01）。[结论]综合疗法治疗慢性盆腔炎效果显著。     

综合治疗慢性盆腔炎120例分析

目的 观察采用综合治疗方法 对慢性盆腔炎的治疗效果.方法 选择慢性盆腔炎患者共240例,随机分为观察组和对照组各120例,对照组给予联合抗生素治疗,观察组则在此基础上联合中药及微波综合治疗,比较两组患者治疗1个疗程后的效果.结果 观察组的总有效率（96.67%）明显高于对照组（80.83%）,差异有统计学意义（P〈0.01）.结论 综合治疗对慢性盆腔炎具有更好的治疗效果.     

Where do people go for treatment of sexually transmitted diseases?

CONTEXT: Major public health resources are devoted to the prevention of sexually transmitted diseases (STDs) through public STD clinics. However, little is known about where people actually receive treatment for STDs. METHODS: As part of the National Health and Social Life Survey, household interviews were performed from February to September 1992 with 3,432 persons aged 18-59. Weighted population estimates and multinomial response methods were used to describe the prevalence of self-reported STDs and patterns of treatment utilization by persons who ever had a bacterial or viral STD. RESULTS: An estimated two million STDs were self-reported in the previous year, and 22 million 18-59-year-olds self-reported lifetime STDs. Bacterial STDs (gonorrhea, chlamydia, nongonococcal urethritis, pelvic inflammatory disease and syphilis) were more common than viral STDs (genital herpes, genital warts, hepatitis and HIV). Genital warts were the most commonly reported STD in the past year, while gonorrhea was the most common ever-reported STD. Almost half of all respondents who had ever had an STD had gone to a private practice for treatment (49%); in comparison, only 5% of respondents had sought treatment at an STD clinic. Respondents with a bacterial STD were seven times more likely to report going to an STD clinic than were respondents with a viral STD--except for chlamydia, which was more likely to be treated at family planning clinics. Men were significantly more likely than women to go to an STD clinic. Young, poor or black respondents were all more likely to use a family planning clinic for STD treatment than older, relatively wealthy or white respondents. Age, sexual history and geographic location did not predict particular types of treatment-seeking. CONCLUSIONS: The health care utilization patterns for STD treatment in the United States are complex. Specific disease diagnosis, gender, race and income status all affect where people will seek treatment. These factors need to be taken into account when STD prevention strategies are being developed.     

Azithromycin failure in Mycoplasma genitalium urethritis

We report significant failure rates (28%, 95% confidence interval 15%-45%) after administering 1 g azithromycin to men with Mycoplasma genitalium-positive nongonococcal urethritis. In vitro evidence supported reduced susceptibility of M. genitalium to macrolides. Moxifloxacin administration resulted in rapid symptom resolution and eradication of infection in all cases. These findings have implications for management of urethritis.     

Self-reported behavior patterns of patients attending a sexually transmitted disease clinic.

Records of the sexually transmitted disease (STD) clinic visits of 12,728 patients in Columbus, Ohio were analyzed to better understand the behavior patterns of these patients. Among heterosexual men, a greater proportion of Blacks than Whites reported a previous history of urethritis. After controlling for previous STD among heterosexual men with discharge or dysuria, we found that Black men sought treatment sooner and were more likely to curtail sexual activity than White men after becoming symptomatic with gonorrhea or nongonococcal urethritis.     

Chlamydiae as agents of sexually transmitted diseases.

Chlamydiae are being increasingly recognized as an important cause of human disease. The known geographical distribution of lymphogranuloma venereum and the role of chlamydiae as agents of sexually transmitted diseases are reviewed. The presence of chlamydiae in the urethra and the cervix, and their etiological relationship to genital infections, first recognized in connexion with ocular infections, have been proved in a number of studies in selected populations in a few countries. Chlamydiae appear to be the most important agent of nongonococcal urethritis, which in some cases appears now to be more frequent than gonococcal urethritis. In addition to their association with cervicitis, chlamydiae appear also to be fairly frequent in the cervix of apparently normal, asymptomatic, and sexually active women. The role of chlamydiae as agents of other human diseases still requires to be clarified. The organisms have been found in association with pelvic inflammatory disease, neonatal pneumonia, pharyngitis, and otitis. There is need for additional studies in view of the fact that effective chemotherapy is available. An outline is given of laboratory methods that may be useful for the diagnosis of chlamydial infections.